Kuldeep Neote, PhD
Dr. Kuldeep Neote consults for the life sciences healthcare sector, with an extensive background in implementing cutting edge scientific discoveries into practical drug discovery programs. Formerly, Dr. Neote was Vice President, External Innovation at Eli Lilly and Senior Director, New Ventures at Johnson & Johnson Innovation. Prior to these leadership roles, he was Research Advisor/Director in Global External R&D at Eli Lilly in Indianapolis, IN and responsible for search and evaluation of Oncology in-licensing opportunities. He started his career as a Discovery Scientist at Pfizer Inc. in Groton, CT, where he initiated the chemokine receptor drug discovery platform that led to the discovery and further development of several clinical candidates. Earlier in his career, Dr. Neote cloned one of the first chemokine receptors while at Genentech. Dr. Neote earned his BSc. in Microbial and Cellular Biology at the University of Calgary, and a PhD in Human and Molecule Genetics at the University of Toronto.